Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7942 USD | -14.04% |
|
-12.73% | -21.37% |
Evolution of the average Target Price on Passage Bio, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Passage Bio, Inc.
Canaccord Genuity | |
Wedbush | |
Chardan Research | |
Raymond James | |
Guggenheim | |
Citigroup | |
Goldman Sachs | |
JPMorgan Chase | |
BTIG | |
Chardan |
EPS Revisions
- Stock Market
- Equities
- PASG Stock
- Consensus Passage Bio, Inc.